Upload
informa-australia
View
92
Download
0
Embed Size (px)
Citation preview
How to determine the critical medication prescribing alerts to include in a hospital EMM system Natalie Page
Pharmacist – Clinical Lead (Informatics), Children’s Health QLD
Former Lead Pharmacist, EMM, ACT Health
Master of Philosophy candidate, CHSSR, AIHI, Macquarie University
Supervisors
Professor Johanna Westbrook, Director, CHSSR, AIHI, Macquarie University
Dr Melissa Baysari, Senior Research Fellow, CHSSR, AIHI, Macquarie University
Background
• Interruptive medication prescribing alerts
• Alert categories
• Configuration options
• Safety benefits vs. alert fatigue
Objectives
• Current research gap
• Thesis aim
To identify critical alerts to include in hospital EMM systems based on evidence and the Australian experience and to develop guidance for implementers
Aims:
1. What is the evidence of the effectiveness of
a) an individual EMM interruptive prescribing alert category, or
b) an alert suite
to change prescriber behaviour and/or improve patient outcomes in the acute hospital inpatient setting?
2. Is there evidence to support the inclusion of an individual medication alert category or alert suite over others in hospital EMM systems?
Systematic Review
Methods
• PubMed, Embase, CINAHL and the Cochrane Library were searched for relevant articles published between January 2000 and February 2016
• Studies were included if they compared the outcomes of automatic, interruptive medication prescribing alert to a control/comparison group to determine alert effectiveness
• 23 studies
• 29 alerts categorised into 11 alert categories
• All 23 studies investigated the impact on prescriber behavior
• One study investigated the impact on patient outcomes
Results
Impact of alert categories on prescriber behaviour
0
1
2
3
4
5
6
Condition DDI DRC Formulary Allergy Duplicate Corollary Adjustment Lab IV compat
Number of studies investigating the impact of alert category on prescriber behaviour
Number of studies reporting significant beneficial effect from alert
Number of studies reporting no significant change from alert
Number of studies reporting significant detrimental effect from alert
0
1
2
3
4
Corollary DDI Adjustment DRC Allergy Condition Lab Duplicate Formulary IV compat IV/po
Number of studies investigating the impact of alert category on patient outcomes
Number of studies reporting significant beneficial effect from alert
Number of studies reporting no significant change from alert
Number of studies reporting significant detrimental effect from alert
Impact of alert categories on patient outcomes
Outcomes
• No clear association between alert category and a beneficial outcome
• Outcomes specific to the impact of an individual alert category (no alert suites)
• No comparison of the relative effectiveness of different alert categories
Conclusion
Current evidence does not support the inclusion of any individual prescribing alert category (or suite of alerts) over others in hospital EMM systems
Continued research is required in demonstrating the effectiveness of interruptive medication alert categories and alert suites
Aim: To determine what interruptive prescribing alert categories are being used in Australian hospital EMM systems, and to explore the experiences and opinions of implementers and the governance processes in place surrounding alert selection.
• Standardised semi-structured survey administered via telephone
• Participants identified via the investigators’ existing networks
• Consent process
• Ethics approval
Australian EMM Alerts Survey
• 15 responders • 14 Pharmacists; 1 Health Information Manager
• Representing EMM implementations at 26 hospitals
• Varying levels of system maturity
Preliminary Survey Results: Demographics
0
1
2
3
4
5
6
7
2004 2005 2007 2009 2010 2011 2012 2013 2014 2015 2016
Year first introduced, including pilots
Nu
mb
er o
f h
osp
ital
s
State/territory of EMM implementation
0
1
2
3
4
5
6
7
8
NSW Vic NT SA ACT Qld
Nu
mb
er o
f h
osp
ital
s
0
1
2
3
4
5
6
7
8
Principal referralhospitals
Children'shospitals
Public acute groupA hospitals
Public acute groupB hospitals
Public acute groupC hospitals
Publicrehabilitation
hospitals
Private acutegroup D hospitals
Psychiatrichospitals
Hospital type (AIHW Classification) N
um
ber
of
ho
spit
als
EMM System Implemented
0
2
4
6
8
10
12
14
MedChart, CSC Millennium, Cerner Sunrise, Allscripts Trakcare, Intersystems Willow Inpatient, EPICSystems
Nu
mb
er o
f h
osp
ital
s
Implementation scope • 1 hospital about to go-live
• 25 hospitals implemented at least in one ward • 12 hospitals have completed implemented hospital-wide in all eligible
inpatient areas • 8 have implemented hospital-wide but have hybrid medication management (i.e. paper charts or a specialty
EMM system) in some areas
• 13 hospitals have not yet implemented hospital-wide • 5 have hybrid medication management (i.e. paper charts or a specialty EMM system) in some areas
• Hybrid systems most frequently in
Operating theatres 11
Chemotherapy treatment 5
Haemodialysis 3
Intensive care 3
Hospital in the home 2
Paediatrics 2
Emergency department 1
Community Health 1
0
5
10
15
20
25
Current Locations Fully Electronic
Hybrid
0
5
10
15
20
25
Future Locations Fully Electronic
Hybrid
Nu
mb
er o
f h
osp
ital
s
Nu
mb
er o
f h
osp
ital
s
Governance
0
1
2
3
4
5
6
7
8
EMM Governance Group QUM/DTC Governance Group CDS Governance Group EMR Governance Group
Governance Models
Nu
mb
er o
f re
spo
nd
ents
Alert Feedback
0
1
2
3
4
5
6
7
8
9
10
Yes No
Solicit Feedback?
Nu
mb
er o
f re
spo
nd
ents
Nu
mb
er o
f re
spo
nd
ents
0
1
2
3
4
Surveys User Groups During go-liveperiod only
FeedAackprocess via
EMM system
Forums
Feedback process
Nu
mb
er o
f re
spo
nd
ents
0
1
2
3
4
5
6
7
8
Yes No
Alerts Evaluated?
0
1
2
3
4
5
6
7
Alert rate Alert overriderate
Impact onprescriberoutcomes
Impact on patientoutcomes
Alert Evaluation Process
Nu
mb
er o
f re
spo
nd
ents
Alert Evaluation
0
5
10
15
20
25
30
Alert Categories in use in Australian EMM systems
Nu
mb
er o
f h
osp
ital
s
Beliefs of implementers
• Beliefs about evidence • To support the use of each alert category
• To improve prescriber behavior
• To improve patient outcomes
• Beliefs about the impact of each alert category at their hospital • To improve prescriber behavior
• To improve patient outcomes
0
2
4
6
8
10
12
14
Agree Neither Disagree
Believe evidence to support alert category
Nu
mb
er o
f re
spo
nd
ents
0
2
4
6
8
10
12
14
Agree Neither Disagree
Believe evidence alert category changes prescriber behaviour
Nu
mb
er o
f re
spo
nd
ents
0
2
4
6
8
10
12
14
Agree Neither Disagree
Nu
mb
er o
f re
spo
nd
ents
Believe evidence alert category improves patient outcomes
0
2
4
6
8
10
12
Agree Neither Disagree
Believe alert category has changed prescriber behaviour at my institution
Nu
mb
er o
f re
spo
nd
ents
0
2
4
6
8
10
12
Agree Neither Disagree
Believe alert category has improved patient outcomes at my institution
Nu
mb
er o
f re
spo
nd
ents
Lessons learned
• Start small • No alert better than poorly designed alert
• Difficult to regain trust if have excessive alert generation • Explore other CDS options before interruptive alerts • Condier who, when why, what, how • Prioritise alerts of benefit to your casemix • Carefully design each alert considering the sensitivity, specificity and user-interface
(informatics and clinician collaboration)
• Transparency of alerts • If you evaluate the impact of your alerts you will refine them No evaluation = No improvement • Refine in response to alert fatigue
1. Continue survey recruitment
2. Complete survey analysis
3. Develop an evidence briefing for implementers on the critical medication prescribing alert/s to include in a hospital EMMS system • Evidence from the literature (results of Systematic Review)
• Experiences and advice of Australian implementers (results of Survey)
• Factors to consider when deciding which individual alert category or alert suite to include in a hospital EMMS system
• Expected completion end 2017
Next Steps
Acknowledgements
• Thank you to all the survey respondents for graciously sharing their time!
For further information
• To contribute to the survey, or receive a copy of the final survey and/or evidence briefing, contact
[email protected] or [email protected],
or via www.linkedin.com/in/natalie-page-14031191